Current
0.76 €
-1.21% today
Start price
12.90 €
Target price
–
End price
9.15 €
Performance (%)
-29.07%
Confidence
50%
Time horizon
2021-11-04
Performance since start
How it ranks
- #93 Rank 93 of 115 by performance
- 92 ratings for this instrument performed better
- 2 other running ratings for this instrument
Summary
This prediction ended on 24.03.21 with a price of €9.15. The price of Cardiff Oncology Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.07%. FXX has 50% into this prediction
Investment thesis
Pros and cons by FXX
For
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Normal challenges to pay loans and raise capital
Some uniques
Against
Risky balance sheet
Timeline & discussion
Reasoning and updates for this rating
The discussion is visible to sharewise members.
2 comments are waiting for you.